|
Sen. Laura Fine
Filed: 3/24/2026
| | 10400SB3750sam001 | | LRB104 20663 KTG 35655 a |
|
|
| 1 | | AMENDMENT TO SENATE BILL 3750
|
| 2 | | AMENDMENT NO. ______. Amend Senate Bill 3750 by replacing |
| 3 | | everything after the enacting clause with the following: |
| 4 | | "Section 5. The Mental Health and Developmental |
| 5 | | Disabilities Code is amended by changing Sections 1-109, |
| 6 | | 1-129, 2-107, 2-107.1, 3-611, and 3-807 and by adding Section |
| 7 | | 1-103.5 as follows: |
| 8 | | (405 ILCS 5/1-103.5 new) |
| 9 | | Sec. 1-103.5. Confinement. "Confinement", with respect to |
| 10 | | a mental health facility, means that an individual is |
| 11 | | prevented or otherwise not permitted to leave the facility. |
| 12 | | (405 ILCS 5/1-109) (from Ch. 91 1/2, par. 1-109) |
| 13 | | Sec. 1-109. "Discharge" means the full and physical |
| 14 | | release of any person admitted or otherwise detained under |
| 15 | | this Act from treatment, habilitation, or care and custody. |
|
| | 10400SB3750sam001 | - 2 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | (Source: P.A. 80-1414.) |
| 2 | | (405 ILCS 5/1-129) |
| 3 | | Sec. 1-129. Mental illness. "Mental illness" means a |
| 4 | | mental, or emotional disorder that substantially impairs a |
| 5 | | person's thought, perception of reality, emotional process, |
| 6 | | judgment, behavior, or ability to cope with the ordinary |
| 7 | | demands of life, but does not include a developmental |
| 8 | | disability, a neurocognitive disorder dementia or Alzheimer's |
| 9 | | disease absent psychosis, a substance use disorder, or an |
| 10 | | abnormality manifested only by repeated criminal or otherwise |
| 11 | | antisocial conduct. |
| 12 | | (Source: P.A. 100-759, eff. 1-1-19.) |
| 13 | | (405 ILCS 5/2-107) (from Ch. 91 1/2, par. 2-107) |
| 14 | | Sec. 2-107. Refusal of services; informing of risks. |
| 15 | | (a) An adult recipient of services or the recipient's |
| 16 | | guardian, if the recipient is under guardianship, and the |
| 17 | | recipient's substitute decision maker, if any, must be |
| 18 | | informed of the recipient's right to refuse medication or |
| 19 | | electroconvulsive therapy. The recipient and the recipient's |
| 20 | | guardian or substitute decision maker shall be given the |
| 21 | | opportunity to refuse generally accepted mental health or |
| 22 | | developmental disability services, including but not limited |
| 23 | | to medication or electroconvulsive therapy. If such services |
| 24 | | are refused, they shall not be given unless such services are |
|
| | 10400SB3750sam001 | - 3 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | necessary to prevent the recipient from causing serious and |
| 2 | | imminent physical harm to the recipient or others and no less |
| 3 | | restrictive alternative is available. The facility director |
| 4 | | shall inform a recipient, guardian, or substitute decision |
| 5 | | maker, if any, who refuses such services of alternate services |
| 6 | | available and the risks of such alternate services, as well as |
| 7 | | the possible consequences to the recipient of refusal of such |
| 8 | | services. |
| 9 | | (b) Psychotropic medication or electroconvulsive therapy |
| 10 | | may be administered under this Section for up to 24 hours only |
| 11 | | if the circumstances leading up to the need for emergency |
| 12 | | treatment are set forth in writing in the recipient's record. |
| 13 | | (c) Administration of medication or electroconvulsive |
| 14 | | therapy may not be continued unless the need for such |
| 15 | | treatment is redetermined at least every 24 hours based upon a |
| 16 | | personal examination of the recipient by a physician or a |
| 17 | | nurse under the supervision of a physician and the |
| 18 | | circumstances demonstrating that need are set forth in writing |
| 19 | | in the recipient's record. |
| 20 | | (d) Neither psychotropic medication nor electroconvulsive |
| 21 | | therapy may be administered under this Section for a period in |
| 22 | | excess of 72 hours, excluding Saturdays, Sundays, and |
| 23 | | holidays, unless a petition is filed under Section 2-107.1 and |
| 24 | | the treatment continues to be necessary under subsection (a) |
| 25 | | of this Section. Once the petition has been filed, treatment |
| 26 | | may continue in compliance with subsections (a), (b), and (c) |
|
| | 10400SB3750sam001 | - 4 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | of this Section until the final outcome of the hearing on the |
| 2 | | petition. |
| 3 | | (e) The Department shall issue rules designed to ensure |
| 4 | | insure that in State-operated mental health facilities |
| 5 | | psychotropic medication and electroconvulsive therapy are |
| 6 | | administered in accordance with this Section and only when |
| 7 | | appropriately authorized and monitored by a physician or a |
| 8 | | nurse under the supervision of a physician in accordance with |
| 9 | | accepted medical practice. The facility director of each |
| 10 | | mental health facility not operated by the State shall issue |
| 11 | | rules designed to ensure insure that in that facility |
| 12 | | psychotropic medication and electroconvulsive therapy are |
| 13 | | administered in accordance with this Section and only when |
| 14 | | appropriately authorized and monitored by a physician or a |
| 15 | | nurse under the supervision of a physician in accordance with |
| 16 | | accepted medical practice. Such rules shall be available for |
| 17 | | public inspection and copying during normal business hours. |
| 18 | | (f) The provisions of this Section with respect to the |
| 19 | | emergency administration of psychotropic medication and |
| 20 | | electroconvulsive therapy do not apply to facilities licensed |
| 21 | | under the Nursing Home Care Act, the Specialized Mental Health |
| 22 | | Rehabilitation Act of 2013, the ID/DD Community Care Act, or |
| 23 | | the MC/DD Act. |
| 24 | | (g) Under no circumstances may long-acting psychotropic |
| 25 | | medications be administered under this Section. |
| 26 | | (h) Whenever psychotropic medication or electroconvulsive |
|
| | 10400SB3750sam001 | - 5 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | therapy is refused pursuant to subsection (a) of this Section |
| 2 | | at least once that day, the physician or advanced practice |
| 3 | | psychiatric nurse shall determine and state in writing the |
| 4 | | reasons why the recipient did not meet the criteria for |
| 5 | | administration of medication or electroconvulsive therapy |
| 6 | | under subsection (a) and whether the recipient meets the |
| 7 | | standard for administration of psychotropic medication or |
| 8 | | electroconvulsive therapy under Section 2-107.1 of this Code. |
| 9 | | If the physician or advanced practice psychiatric nurse |
| 10 | | determines that the recipient meets the standard for |
| 11 | | administration of psychotropic medication or electroconvulsive |
| 12 | | therapy under Section 2-107.1, the facility director or his or |
| 13 | | her designee shall petition the court for administration of |
| 14 | | psychotropic medication or electroconvulsive therapy pursuant |
| 15 | | to that Section unless the facility director or his or her |
| 16 | | designee states in writing in the recipient's record why the |
| 17 | | filing of such a petition is not warranted. This subsection |
| 18 | | (h) applies only to State-operated mental health facilities. |
| 19 | | (i) The Department shall conduct annual trainings for all |
| 20 | | physicians and registered nurses working in State-operated |
| 21 | | mental health facilities on the appropriate use of emergency |
| 22 | | administration of psychotropic medication and |
| 23 | | electroconvulsive therapy, standards for their use, and the |
| 24 | | methods of authorization under this Section. |
| 25 | | (Source: P.A. 98-104, eff. 7-22-13; 99-180, eff. 7-29-15.) |
|
| | 10400SB3750sam001 | - 6 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | (405 ILCS 5/2-107.1) (from Ch. 91 1/2, par. 2-107.1) |
| 2 | | Sec. 2-107.1. Administration of psychotropic medication |
| 3 | | and electroconvulsive therapy upon application to a court. |
| 4 | | (a) (Blank). |
| 5 | | (a-5) Notwithstanding the provisions of Section 2-107 of |
| 6 | | this Code, psychotropic medication and electroconvulsive |
| 7 | | therapy may be administered to an adult recipient of services |
| 8 | | on an inpatient or outpatient basis without the informed |
| 9 | | consent of the recipient under the following standards: |
| 10 | | (1) Any person 18 years of age or older, including any |
| 11 | | guardian, may petition the circuit court for an order |
| 12 | | authorizing the administration of psychotropic medication |
| 13 | | and electroconvulsive therapy to a recipient of services. |
| 14 | | The petition shall state that the petitioner has made a |
| 15 | | good faith attempt to determine whether the recipient has |
| 16 | | executed a power of attorney for health care under the |
| 17 | | Powers of Attorney for Health Care Law or a declaration |
| 18 | | for mental health treatment under the Mental Health |
| 19 | | Treatment Preference Declaration Act and to obtain copies |
| 20 | | of these instruments if they exist. If either of the |
| 21 | | above-named instruments is available to the petitioner, |
| 22 | | the instrument or a copy of the instrument shall be |
| 23 | | attached to the petition as an exhibit. The petitioner |
| 24 | | shall deliver a copy of the petition, and notice of the |
| 25 | | time and place of the hearing, to the respondent, his or |
| 26 | | her attorney, any known agent or attorney-in-fact, if any, |
|
| | 10400SB3750sam001 | - 7 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | and the guardian, if any, no later than 3 days prior to the |
| 2 | | date of the hearing. Service of the petition and notice of |
| 3 | | the time and place of the hearing may be made by |
| 4 | | transmitting them via facsimile machine or secured |
| 5 | | electronic mail to the respondent or other party. Upon |
| 6 | | receipt of the petition and notice, the party served, or |
| 7 | | the person delivering the petition and notice to the party |
| 8 | | served, shall acknowledge service. If the party sending |
| 9 | | the petition and notice does not receive acknowledgement |
| 10 | | of service within 24 hours, service must be made by |
| 11 | | personal service. A petition requesting that the court |
| 12 | | authorize treatment with psychotropic medication shall |
| 13 | | specify the full names of the medications and anticipated |
| 14 | | range of dosage that comprise such treatment. The petition |
| 15 | | also may include a request that the court authorize |
| 16 | | alternative or alternate treatments with psychotropic |
| 17 | | medications, but only where the petition sets forth the |
| 18 | | psychotropic medications and the anticipated range of |
| 19 | | dosages for each alternative or alternate and each |
| 20 | | combination of psychotropic medications that may be |
| 21 | | administered simultaneously. |
| 22 | | The petition may include a request that the court |
| 23 | | authorize such testing and procedures as may be essential |
| 24 | | for the safe and effective administration of the |
| 25 | | psychotropic medication or electroconvulsive therapy |
| 26 | | sought to be administered, but only where the petition |
|
| | 10400SB3750sam001 | - 8 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | sets forth the specific testing and procedures sought to |
| 2 | | be administered. |
| 3 | | If a hearing is requested to be held immediately |
| 4 | | following the hearing on a petition for involuntary |
| 5 | | admission, then the notice requirement shall be the same |
| 6 | | as that for the hearing on the petition for involuntary |
| 7 | | admission, and the petition filed pursuant to this Section |
| 8 | | shall be filed with the petition for involuntary |
| 9 | | admission. |
| 10 | | (2) The court shall hold a hearing within 7 days of the |
| 11 | | filing of the petition. The People, the petitioner, or the |
| 12 | | respondent shall be entitled to a continuance of up to 7 |
| 13 | | days as of right. An additional continuance of not more |
| 14 | | than 7 days may be granted to any party (i) upon a showing |
| 15 | | that the continuance is needed in order to adequately |
| 16 | | prepare for or present evidence in a hearing under this |
| 17 | | Section or (ii) under exceptional circumstances. The court |
| 18 | | may grant an additional continuance not to exceed 21 days |
| 19 | | when, in its discretion, the court determines that such a |
| 20 | | continuance is necessary in order to provide the recipient |
| 21 | | with an examination pursuant to Section 3-803 or 3-804 of |
| 22 | | this Act, to provide the recipient with a trial by jury as |
| 23 | | provided in Section 3-802 of this Act, or to arrange for |
| 24 | | the substitution of counsel as provided for by the |
| 25 | | Illinois Supreme Court Rules. The hearing shall be |
| 26 | | separate from a judicial proceeding held to determine |
|
| | 10400SB3750sam001 | - 9 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | whether a person is subject to involuntary admission but |
| 2 | | may be heard immediately preceding or following such a |
| 3 | | judicial proceeding and may be heard by the same trier of |
| 4 | | fact or law as in that judicial proceeding. |
| 5 | | (3) Unless otherwise provided herein, the procedures |
| 6 | | set forth in Article VIII of Chapter III of this Act, |
| 7 | | including the provisions regarding appointment of counsel, |
| 8 | | shall govern hearings held under this subsection (a-5). |
| 9 | | (4) Psychotropic medication and electroconvulsive |
| 10 | | therapy may be administered to the recipient if and only |
| 11 | | if it has been determined by clear and convincing evidence |
| 12 | | that: all of the following factors are present. In |
| 13 | | determining whether a person meets the criteria specified |
| 14 | | in the following paragraphs (A) through (G), the court may |
| 15 | | consider evidence of the person's history of serious |
| 16 | | violence, repeated past pattern of specific behavior, |
| 17 | | actions related to the person's illness, or past outcomes |
| 18 | | of various treatment options. |
| 19 | | (A) That the recipient has a serious mental |
| 20 | | illness or developmental disability; . |
| 21 | | (B) That because of said mental illness or |
| 22 | | developmental disability, the recipient currently |
| 23 | | exhibits any one of the following: (i) deterioration |
| 24 | | of his or her ability to function, as compared to the |
| 25 | | recipient's ability to function prior to the current |
| 26 | | onset of symptoms of the mental illness or disability |
|
| | 10400SB3750sam001 | - 10 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | for which treatment is presently sought, (ii) |
| 2 | | suffering, or (iii) threatening behavior; . |
| 3 | | (C) That the illness or disability has existed for |
| 4 | | a period marked by the continuing presence of the |
| 5 | | symptoms set forth in item (B) of this subdivision (4) |
| 6 | | or the repeated episodic occurrence of these |
| 7 | | symptoms; . |
| 8 | | (D) That the benefits of the treatment outweigh |
| 9 | | the harm; . |
| 10 | | (E) That the recipient lacks the capacity to make |
| 11 | | a reasoned decision about the treatment; . |
| 12 | | (F) That other less restrictive services have been |
| 13 | | explored and found inappropriate; and . |
| 14 | | (G) if If the petition seeks authorization for |
| 15 | | testing and other procedures, that such testing and |
| 16 | | procedures are essential for the safe and effective |
| 17 | | administration of the treatment. |
| 18 | | (4.5) In determining whether there is clear and |
| 19 | | convincing evidence, the court may consider evidence |
| 20 | | presented, if any, about a recipient's history of serious |
| 21 | | violence, repeated past pattern of specific behavior |
| 22 | | related to the recipient's illness, or outcomes of past |
| 23 | | treatments. |
| 24 | | (5) In no event shall an order issued under this |
| 25 | | Section be effective for more than 90 days. A second |
| 26 | | 90-day period of involuntary treatment may be authorized |
|
| | 10400SB3750sam001 | - 11 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | pursuant to a hearing that complies with the standards and |
| 2 | | procedures of this subsection (a-5). Thereafter, |
| 3 | | additional 180-day periods of involuntary treatment may be |
| 4 | | authorized pursuant to the standards and procedures of |
| 5 | | this Section without limit. If a new petition to authorize |
| 6 | | the administration of psychotropic medication or |
| 7 | | electroconvulsive therapy is filed at least 15 days prior |
| 8 | | to the expiration of the prior order, and if any |
| 9 | | continuance of the hearing is agreed to by the recipient, |
| 10 | | the administration of the treatment may continue in |
| 11 | | accordance with the prior order pending the completion of |
| 12 | | a hearing under this Section. |
| 13 | | (6) An order issued under this subsection (a-5) shall |
| 14 | | designate the persons authorized to administer the |
| 15 | | treatment under the standards and procedures of this |
| 16 | | subsection (a-5). Those persons shall have complete |
| 17 | | discretion not to administer any treatment authorized |
| 18 | | under this Section. The order shall also specify the |
| 19 | | medications and the anticipated range of dosages that have |
| 20 | | been authorized and may include a list of any alternative |
| 21 | | medications and range of dosages deemed necessary. In |
| 22 | | addition, the order may authorize the administration of |
| 23 | | any alternative or alternate treatment that is requested |
| 24 | | in the petition and for which the court finds clear and |
| 25 | | convincing evidence that the benefits of the alternative |
| 26 | | or alternate treatment outweigh the harm and the recipient |
|
| | 10400SB3750sam001 | - 12 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | lacks the capacity to make a reasoned decision about the |
| 2 | | treatment. The medications and the anticipated range of |
| 3 | | dosages for any alternative or alternate treatment that |
| 4 | | the court authorizes shall be included in the order. Where |
| 5 | | the simultaneous use of multiple psychotropic medications |
| 6 | | is authorized, the order shall specify the combinations |
| 7 | | that are authorized. |
| 8 | | (a-10) The court may, in its discretion, appoint a |
| 9 | | guardian ad litem for a recipient before the court or |
| 10 | | authorize an existing guardian of the person to monitor |
| 11 | | treatment and compliance with court orders under this Section. |
| 12 | | (b) A guardian may be authorized to consent to the |
| 13 | | administration of psychotropic medication or electroconvulsive |
| 14 | | therapy to an objecting recipient only under the standards and |
| 15 | | procedures of subsection (a-5). |
| 16 | | (c) Notwithstanding any other provision of this Section, a |
| 17 | | guardian may consent to the administration of psychotropic |
| 18 | | medication or electroconvulsive therapy to a non-objecting |
| 19 | | recipient under Article XIa of the Probate Act of 1975. |
| 20 | | (d) Nothing in this Section shall prevent the |
| 21 | | administration of psychotropic medication or electroconvulsive |
| 22 | | therapy to recipients in an emergency under Section 2-107 of |
| 23 | | this Act. |
| 24 | | (e) Notwithstanding any of the provisions of this Section, |
| 25 | | psychotropic medication or electroconvulsive therapy may be |
| 26 | | administered pursuant to a power of attorney for health care |
|
| | 10400SB3750sam001 | - 13 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | under the Powers of Attorney for Health Care Law or a |
| 2 | | declaration for mental health treatment under the Mental |
| 3 | | Health Treatment Preference Declaration Act over the objection |
| 4 | | of the recipient if the recipient has not revoked the power of |
| 5 | | attorney or declaration for mental health treatment as |
| 6 | | provided in the relevant statute. |
| 7 | | (f) The Department shall conduct annual trainings for |
| 8 | | physicians and registered nurses working in State-operated |
| 9 | | mental health facilities on the appropriate use of |
| 10 | | psychotropic medication and electroconvulsive therapy, |
| 11 | | standards for their use, and the preparation of court |
| 12 | | petitions under this Section before any such psychiatrists or |
| 13 | | advanced practice psychiatric nurses may petition the court or |
| 14 | | testify at a hearing under this Section. |
| 15 | | (Source: P.A. 100-710, eff. 8-3-18.) |
| 16 | | (405 ILCS 5/3-611) (from Ch. 91 1/2, par. 3-611) |
| 17 | | Sec. 3-611. Filing petition, first certificate, and proof |
| 18 | | of service. |
| 19 | | (a) Within 24 hours, excluding Saturdays, Sundays and |
| 20 | | holidays, after the respondent's admission under this Article, |
| 21 | | the facility director of the facility shall file 2 copies of |
| 22 | | the petition, the first certificate, and proof of service of |
| 23 | | the petition and statement of rights upon the respondent with |
| 24 | | the court in the county in which the facility is located. |
| 25 | | (b) Upon completion of the second certificate, the |
|
| | 10400SB3750sam001 | - 14 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | facility director shall promptly file it with the court and |
| 2 | | provide a copy to the respondent. |
| 3 | | (c) The facility director shall make copies of the |
| 4 | | certificates available to the attorneys for the parties upon |
| 5 | | request. |
| 6 | | (d) Upon the filing of the petition and first certificate, |
| 7 | | the court shall set a hearing to be held within 5 days, |
| 8 | | excluding Saturdays, Sundays and holidays, after receipt of |
| 9 | | the petition. The court shall direct that notice of the time |
| 10 | | and place of the hearing be served upon the respondent, his |
| 11 | | responsible relatives, and the persons entitled to receive a |
| 12 | | copy of the petition pursuant to Section 3-609. |
| 13 | | (e) For purposes of this Section, (1) a respondent is |
| 14 | | admitted to a mental health facility at the earlier of the |
| 15 | | respondent's confinement or receipt of treatment and (2) a |
| 16 | | respondent who is ordered discharged in accordance with |
| 17 | | Section 3-809 or subsection (b) of Section 3-901, or |
| 18 | | discharged upon notice by the facility director as provided by |
| 19 | | subsection (a) of Section 3-903, remains admitted to a mental |
| 20 | | health facility until the respondent is physically released |
| 21 | | from the mental health facility and thereafter physically |
| 22 | | enters a mental health facility. |
| 23 | | (Source: P.A. 98-865, eff. 8-8-14.) |
| 24 | | (405 ILCS 5/3-807) (from Ch. 91 1/2, par. 3-807) |
| 25 | | Sec. 3-807. Testimony. No respondent may be found subject |
|
| | 10400SB3750sam001 | - 15 - | LRB104 20663 KTG 35655 a |
|
|
| 1 | | to involuntary admission on an inpatient or outpatient basis |
| 2 | | unless at least one psychiatrist, clinical social worker, |
| 3 | | clinical psychologist, advanced practice psychiatric nurse, or |
| 4 | | qualified examiner who has examined the respondent testifies |
| 5 | | in person at the hearing. No administration of psychotropic |
| 6 | | medication or electroconvulsive therapy without the informed |
| 7 | | consent of the recipient may be authorized unless at least one |
| 8 | | psychiatrist or advanced practice psychiatric nurse who has |
| 9 | | examined the recipient testifies in person at the hearing. The |
| 10 | | respondent may waive the requirement of the testimony subject |
| 11 | | to the approval of the court. |
| 12 | | (Source: P.A. 101-587, eff. 1-1-20.)". |